dc.contributor.author | Strand, Tor A | |
dc.contributor.author | Frøyland, Livar | |
dc.contributor.author | Haugen, Margaretha | |
dc.contributor.author | Holvik, Kristin | |
dc.contributor.author | Løvik, Martinus | |
dc.contributor.author | Tell, Grethe S. | |
dc.contributor.author | Vaktskjold, Arild | |
dc.contributor.author | Iversen, Per Ole | |
dc.date.accessioned | 2017-10-20T08:03:48Z | |
dc.date.available | 2017-10-20T08:03:48Z | |
dc.date.created | 2017-10-19T10:48:59Z | |
dc.date.issued | 2015 | |
dc.identifier.isbn | 978-82-8259-175-1 | |
dc.identifier.uri | http://hdl.handle.net/11250/2461181 | |
dc.description.abstract | The Norwegian Scientific Committee for Food Safety (VKM) has, at the request of the Norwegian Food Safety Authority, assessed the risk of specified doses of L-cysteine and L-cystine in food supplements. VKM concludes that:
• In adolescents (14 to <18 years) and adults (≥18 years), the specified doses 10 mg/day L-cysteine and 250, 500 and 750 mg/day L-cystine in food supplements are considered to be unlikely to cause adverse health effects, whereas the dose 1000 mg L-cystine per day may represent a risk of adverse health effects.
• In children (10 to <14 years), the specified doses 10 mg/day L-cysteine and 250 and 500 mg/day L-cystine in food supplements are considered to be unlikely to cause adverse health effects, whereas the doses 750 and 1000 mg L-cystine per day may represent a risk of adverse health effects. | nb_NO |
dc.language.iso | eng | nb_NO |
dc.publisher | Norwegian Committee for Food Safety (VKM) | nb_NO |
dc.relation.ispartof | VKM Report | |
dc.relation.ispartofseries | VKM Report; | |
dc.relation.uri | Opinion of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy of the Norwegian Scientific Committee for Food Safety | |
dc.title | Risk assessment of “other substances” - L-cysteine and L-cystine. Opinion of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy of the Norwegian Scientific Committee for Food Safety | nb_NO |
dc.type | Research report | nb_NO |
dc.description.version | publishedVersion | nb_NO |
dc.source.pagenumber | 44 | nb_NO |
dc.source.issue | 2015: 20 | nb_NO |
dc.identifier.cristin | 1505824 | |
cristin.unitcode | 194,65,15,0 | |
cristin.unitname | Institutt for klinisk og molekylær medisin | |
cristin.ispublished | true | |
cristin.fulltext | original | |